Skip to main content

Table 1 Baseline characteristics of NSCLC patients according to RDW status

From: Red blood cell distribution width is associated with sarcopenia risk in early-stage non-small cell lung cancer

Variables

Total

RDW ≤ 12.9

RDW > 12.9    

p-value

 

n (%)  

n (%)

n (%)

 

Age (years)

   

0.240

 ≤ 60

219 (57.9)

157 (59.9)

62 (53.4)

 

 > 60

159 (42.1)  

105 (40.1)

54 (46.6)

 

Gender

   

0.604

 Male

177 (46.8)

125 (47.7)

52 (44.8)

 

 Female

201 (53.2)

137 (52.3)

64 (55.2)

 

Current smoker

   

0.441

 Yes

104 (27.5)

69 (26.3)

35 (30.2)

 

 No

274 (72.5)

193 (73.7)

81 (69.8)

 

Pack-years of smoking

8.9 ± 17.4

9.0 ± 16.8

8.9 ± 17.7

0.941

Current drinker

   

0.727

 Yes

275 (72.8)

70 (26.7)

33 (28.4)

 

 No

119 (44.1)

192 (73.3)

83 (71.6)

 

Hypertension

   

0.054

 Yes

75 (19.9)

59 (22.5)

16 (13.9)

 

 No

302 (80.1)

203 (77.5)

99 (86.1)

 

Diabetes

   

0.135

 Yes

47 (12.4)

37 (14.1)

10 (8.6)

 

 No

331 (87.6)

225 (85.9)

106 (91.4)

 

Comorbidities

   

0.001

 Yes

184 (48.7)

142 (54.2)

74 (63.8)

 

 No

194 (51.3)

120 (45.8)

42 (36.2)

 

Tumor size

   

0.969

 > 4cm

55 (14.6)

38 (14.5)

17 (14.7)

 

 ≤ 4cm

323 (85.4)

224 (85.5)

99 (85.3)

 

Histological type

   

0.002

 AD

319 (84.4)

88 (75.9)

231 (88.2)

 

 SCC

59 (15.6)

28 (24.1)

31 (11.8)

 

T stage

   

0.960

 T1+T2

345 (91.3)

239 (91.2)

106 (91.4)

 

 T3+T4

33 (8.7)

23 (8.8)

10 (8.6)

 

Lymph node status

   

0.592

 Negative

255 (67.5)

 179 (68.3)

76 (65.5)

 

 Positive

123 (32.5)

  83 (31.7)

40 (34.5)

 

Cancer stage

   

0.032

 I/II

 305 (80.7

219 (83.6)

86 (74.1)

 

 III

 73 (19.3)

43 (16.4)

30 (25.9)

 

Sarcopenia

   

< 0.001

 Yes

 137 (36.2)

77 (29.4)

  60 (51.7)

 

 No

241 (63.8)

185 (70.6)

 56 (48.3)